Strattera vs. Focalin
See how Strattera and Focalin compare on approved uses, dosing, side effects, and cost.
Key Takeaways
Strattera is a non-stimulant taken daily that is not a controlled substance, while Focalin is a Schedule II stimulant taken twice daily with a higher abuse risk.
Focalin tends to work within an hour, while Strattera can take several weeks to reach its full effect on ADHD symptoms.
Both are FDA-approved for ADHD in ages 6 and up, but they differ sharply in side effect profile, dosing schedule, and monitoring needs.
Strattera vs. Focalin Drug Summary
Strattera
Strattera (atomoxetine) is a selective norepinephrine reuptake inhibitor, a non-stimulant medication approved to treat ADHD in patients 6 years and older. It's taken as a capsule once daily or split into two doses, and its full effect can take several weeks to build.
Focalin
Focalin (dexmethylphenidate) is a CNS stimulant, the active form of methylphenidate, approved to treat ADHD in adults and children 6 and older. It's taken as an immediate-release tablet twice daily, spaced at least 4 hours apart, and works within about an hour.
Strattera vs. Focalin Side Effects
Strattera
Focalin
Strattera vs. Focalin Dosage
Strattera
Focalin
| STAGE | DOSE | WHEN |
| Starting dose | 0.5 mg/kg/day | Days 1-3 |
| Maximum dose | 100 mg once daily | Week 5 onward |
| Dose changes | 4 increases | As tolerated |
| STAGE | DOSE | WHEN |
| Starting dose | 2.5 mg twice daily | At the start |
| Maximum dose | 10 mg twice daily | If needed |
| Dose changes | 2 increases | As tolerated |
Strattera
| STAGE | DOSE | WHEN |
| Starting dose | 0.5 mg/kg/day | Days 1-3 |
| Maximum dose | 100 mg once daily | Week 5 onward |
| Dose changes | 4 increases | As tolerated |
Focalin
| STAGE | DOSE | WHEN |
| Starting dose | 2.5 mg twice daily | At the start |
| Maximum dose | 10 mg twice daily | If needed |
| Dose changes | 2 increases | As tolerated |
Strattera vs. Focalin Indications
Strattera
Strattera is FDA-approved to treat ADHD in children, adolescents, and adults age 6 and up. It is not approved for narcolepsy or depression, despite its effect on norepinephrine. Doctors often choose it when a patient has a history of substance misuse or prefers a non-stimulant option.
FDA-approved for ADHD ages 6 and up
Not approved for narcolepsy or depression
Often chosen for patients with substance misuse history
Can be combined with stimulant medication off-label
Focalin
Focalin is FDA-approved to treat ADHD in adults and children age 6 and up. It is not approved for use in children under 6, for severe anxiety or agitation, or in patients with glaucoma. As a stimulant, it is used cautiously in patients with a personal or family history of tics or Tourette's syndrome.
FDA-approved for ADHD in adults and children 6+
Not approved for children under age 6
Avoided in patients with glaucoma
Used cautiously with tic or Tourette's history
Strattera vs. Focalin Pros and Cons
Strattera
Strattera works through a different mechanism than stimulants, so it carries no abuse potential and is not a controlled substance. It takes longer to reach full effect and carries a boxed warning about suicidal thoughts in young patients that Focalin does not have.
Pros
Not a controlled substance, so no refill restrictions
No stimulant-related abuse or misuse potential
Once-daily dosing option simplifies routine
Option for patients with substance use history
Cons
Takes several weeks to reach full effect
Carries boxed warning for suicidal ideation in youth
Higher list price than generic stimulant options ($394 to $461 per month)
More gastrointestinal side effects reported
Focalin
Focalin acts quickly, often within an hour, making it useful when fast symptom control matters. As a Schedule II stimulant, it carries a boxed warning for abuse and dependence and requires careful prescription tracking.
Pros
Works within about an hour of taking a dose
Lower list price than atomoxetine ($60 to $150 per month)
Lower milligram dosing than standard methylphenidate
Long track record as a stimulant option
Cons
Schedule II controlled substance with abuse potential
Requires twice-daily dosing spaced 4+ hours apart
Not recommended for patients with tic disorders
Boxed warning for abuse, misuse, and addiction risk
Common Symptoms and Related Diseases You Can Explore
Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.